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Variolaneeded to study monkeypox virus (MPXV) as human monkeypox clinically
resembles smallpox and MPXV is a zoonotic and potential bioterroristic agent. We have demonstrated that a
species of African dormice, Graphiurus kelleni, is susceptible to a lethal infection of MPXV and that MPXV
replicated in multiple organs of this species. Following intranasal administration, MPXV replicated locally in
the nasal mucosa causing necrosis and hemorrhage with subsequent systemic spread to lymph nodes, spleen,
liver, and other tissues where it caused severe necrosis and/or hemorrhage leading to death. The dormouse
model was validated for testing prophylactic (Dryvax vaccine) and therapeutic (cidofovir) test articles against
intranasal challenges with MPXV.
© 2008 Elsevier Inc. All rights reserved.IntroductionSuitable animal models are needed to study MPXV since human
monkeypox clinically resembles smallpox and MPXV is a zoonotic and
potential bioterroristic agent (Parker et al., 2007). The black-tailed
prairie dog (p.d), Cynomys ludovicianus, and the thirteen-lined ground
squirrel (g.s.), Spermophilus tridecemlineatus, have been evaluated and
investigated for their suitability as animal models for MPXV research
(Guarner et al., 2004; Langohr et al., 2004; Sbrana et al., 2007; Tesh et
al., 2004; Xiao et al., 2005). Husbandry issues associated with these
species make them challenging to propagate and maintain in a
research vivarium. Female p.d. produce only one litter each year
(Hoogland, 2001) while g.s. hibernate for part of the year and produce
only one litter each year (Vaughan et al., 2006). Consequently, these
species are obtained from their natural habitat where their health
status is undeﬁned. Another potential experimental host for MPXV is
an African dormouse, Graphiurus kelleni, which is a mouse-sized
rodent found in areas of Africa where human monkeypox hasjsagartz@7thwavelabs.com
.edu (R.M.L. Buller).
mparative Pathobiology, Johns
21205, USA. Fax: +1 443 287
l rights reserved.occurred. Graphiurus spp. were in the shipment of African rodents
that introduced MPXV into the U.S. in 2003. The Centers for Disease
Control and Prevention (CDC) determined that Graphiurus spp. and
other rodents from this shipment tested positive for MPXV (CDC,
2003). Fortunately, this species has many characteristics similar to
laboratory mice which enables their propagation and maintenance in
a research setting; in a vivarium, they were determined to be non-
seasonally polyestrous, litter bearing, and lacking a need for hiberna-
tion. Here we show that G. kelleni (dormice/dormouse) is highly
susceptible to lethal infections with MPXV-ZAI-79 and can be used to
evaluate prophylactics and therapeutics against MPXV.
Results
Morbidity and mortality of dormice following intranasal infection
with MPXV-ZAI-79
Initially, dormice were infected with MPXV-ZAI-79 (1.4×104 PFU/
dormouse) via a footpad injection route; mortality was 92% (12 of 13
dormice) which occurred during days 7–10 p.i. Considering that
smallpox and monkeypox infections are typically initiated by the
deposition of large respiratory droplets containing small quantities of
virions on the respiratory epithelium, likely in the upper respiratory
tract (Fenner et al., 1988; Parker et al., 2007), we infected dormice
(n=55) with a small (10 μl) volume of MPXV-ZAI-79 virus suspension
at various doses by the intranasal (i.n.) route. The dormicewere highly
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(Figs. 1A,B). Virus doses of 2000 and 200 plaque forming units (PFU)/
dormouse were lethal for 100% of dormice with a mean time to death
of 7.9±1 and 8.7±1 days and highest mean body weight change of
−21% and −14%, respectively. Infection with 20 PFU/dormouse was
63% lethal (mean time to death: 12.0±5 days) with the highest mean
body weight change of −6%. Infection with 2 PFU/dormouse was 38%
lethal (mean time to death: 12.3±5 days) with the highest mean body
weight change of +3%. No mortality was observed at 0.2 PFU/
dormouse and the highest mean body weight change was +6%.
Morbidity of dormice that died due to a lethal MPXV-ZAI-79 infection
was decreased activity, hunched posture, unkempt hair coat, dehy-
dration, and conjunctivitis. There were no signiﬁcant differences for
day of death attributed to gender (female: 9.64; male: 9.58; p=0.973).
Mortality was 100% for both genders at a virus dose of 2000 and
200 PFU/dormouse; mortality was 50% and 25% for females and 75%
and 50% for males at the virus doses of 20 and 2 PFU/dormouse,
respectively. The calculated LD50 (Reed and Muench, 1938) of MPXV-
ZAI-79 in dormice following i.n. infection was 12 PFU.Fig. 1.Mortality and mean body weight of dormice following i.n. infectionwith increasing do
post-inoculation of survivors.For comparative purposes, dormice were infected via the intrana-
sal route with MPXV-COP-58, a MPXV strain originating from West
Africa and isolated from imported cynomolgus macaques in Copenha-
gen, Denmark in 1958 (Von Magnus et al., 1959). This strain is less
virulent to humans and primates than MPXV-ZAI-79 (Chen et al.,
2005). Dormice infected with various doses of MPXV-COP-58 had
similar days of death and mortality rates as dormice infected with
similar doses of MPXV-ZAI-79.
Kinetics of virus spread and progression of disease in dormice following a
lethal intranasal MPXV-ZAI-79 infection
Dormice were infected with 2×104 PFU of MPXV-ZAI-79 by the i.n.
route. At designated times following infection, dormice were
sacriﬁced and nasal lavages, blood and selected tissueswere examined
for virus titers and/or histopathology (Fig. 2). MPXV-ZAI-79 was ﬁrst
detected in nasal lavages on day 2 p.i. in 6 of 8 dormice (75%).
Detectable levels of MPXV-ZAI-79 were noted in the spleen starting
day 3 p.i. for 2 of the 8 dormice (25%) sacriﬁced and in the liver, lung,ses of MPXV-ZAI-79 (n=55; female=28, male=27). (A) Mortality; (B) mean body weight
Fig. 2. Spread MPXV-ZAI-79 in dormice following an i.n. infection (n=59; female=30, male=29).
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sacriﬁced, respectively; all positive tissues on day 4 were from
different dormice. The highest level of MPXV-ZAI-79 was found in
liver tissue on day 8 p.i., with 6 of the 6 dormice demonstrating
detectable levels (100%). Day 8 was the last day when surviving
dormicewere available for evaluation. The temporal similarity of virus
detection in spleen, liver, and lung suggest that the lung was infected
through lymphatic and/or hematogenous spread of the virus and not
through aspiration from the upper respiratory tract.
After days 3 and 4 p.i., all dormice clinically demonstrated
dehydration and conjunctivitis. At necropsy, upper gastrointestinal
hemorrhage (Fig. 3), hepatomegaly, and lymphadenopathy were
observed. Histopathologically, infected dormice sacriﬁced late in
infection (starting days 4–5 p.i.) exhibited rhinitis (Figs. 4B–D),
lymphoid necrosis in the submandibular lymph nodes (draining siteFig. 3. Left: stomach from an uninfected dormouse; right: stomach from a dormouse
that received a lethal dose of MPXV-ZAI-79. Petechial and ecchymotic hemorrhages are
evident from the serosal surface. The upper gastrointestinal tract (stomach and small
intestine) were ﬁlled with blood and devoid of ingesta.of infection; Figs. 4F–H), spleen (Figs. 4J–L) and thymus. There was
also hepatocellular necrosis in the liver (Figs. 4N–P). Hemorrhage was
observed in the lungs, stomach, small intestine and elsewhere while
areas of necrosis and myeloid hyperplasia were demonstrated in the
bone marrow. In dormice found dead (pooled from many experi-
ments), there was often hemorrhage from the nasal cavity as well as
hemorrhage in the gall bladder (Fig. 5A) and brain (Fig. 5B) in addition
to the lesions described above. In this and other studies, syncytial cell
formation was present in nasal mucosal epithelial cells (Fig. 5C), and
intracytoplasmic Guarnieri or basophilic (B)-type viral inclusionswere
noted in the liver (Fig. 5D), spleen, and nasal mucosa.
In summary, histopathological changes found in dormice (pooled
from many experiments) which died due to a lethal MPXV-ZAI-79
infection are listed in Table 1 where necrosis and/or hemorrhage
affecting many organs were common features.
Use of dormice for evaluating prophylactics and therapeutics
against MPXV-ZAI-79
To determine if the dormouse was suitable for efﬁcacy testing of
prophylactics and therapeutics, we examined the ability of the Dryvax
(smallpox) vaccine and amarketed antiviral, cidofovir, to protect against
a lethal i.n. challengewithMPXV-ZAI-79 (Table 2). Dormice immunized
4 weeks previously with Dryvax vaccine were solidly protected from
mortality when challenged with 2×104 PFU of MPXV-ZAI-79, whereas
dormice in the non-vaccinated control group experienced uniform
mortality. Dormice treated with a single dose of cidofovir 4 h following
challenge with MPXV-ZAI-79 (pooled results from 3 independent
experiments: infecting doses of 75, 4×103, and 5×103 PFU) were
signiﬁcantly protected from mortality, whereas dormice in the vehicle
treated control group experienced uniform mortality.
Discussion
Many of the histopathological features of MPXV infected dormice
are similar to those observed in smallpox infected humans (Bras,1952;
Fig. 4.Histopathologic changes in selected tissues of dormice following a lethal i.n. infectionwithMPXV-ZAI-79; same study as in Fig. 2. (A–D) Nasal mucosa, bar=20 μm. Submucosal
inﬂammation, mucosal necrosis (arrow) and erosion/ulceration were observed with increasing severity over time; (E–H) submandibular lymph node, bar=100 μm. Necrosis (arrow)
increased in severity and distribution over time; (I–L) Spleen, bar=20 μm. Increased death of lymphocytes were followed by the development of patchy areas of necrosis (arrow) over
time; (M–P) Liver, bar=100 μm. Large necrotic foci (arrows) of hepatic parenchyma were observed at 8 days p.i., which corresponded to maximal viral load in this tissue.
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ing histopathology of humans that died due to a MPXV infection do
not exist. Martin (2002) reviewed accessible cases of smallpox
pathology and review articles from English language journals written
during the last 200 years. He classiﬁed smallpox into 3 subtypes:
variola vera, modiﬁed variola, and hemorrhagic/toxic variola. Variola
vera comprised N90% of cases with a case fatality rate of 30%. Modiﬁed
variola represented a variable number of cases with a case fatality rate
of 3%; this subtype occurred in previously vaccinated humans.
Hemorrhagic/toxic variola comprised b10% of cases with a case
fatality rate of nearly 100% and was characterized by lesions with
bleeding diathesis and disseminated intravascular coagulation. The
MPXV-dormouse model described in this paper most resembles the
hemorrhagic/toxic smallpox subtype and provides a more severe
disease course than other rodent models of humanMPXV disease. The
mechanism for severe hemorrhage in dormice infected with a lethal
dose of MPXV-ZAI-79 was not determined. Extensive liver and bonemarrow necrosis may have resulted in reduced coagulation ability due
to the loss of clotting factors and platelets. Additionally, infection and
damage of endothelium in affected tissues may have contributed to
the multiorgan hemorrhage.
The prairie dog and ground squirrel have been examined as
potential rodent models of human MPXV disease. The prairie dog has
been experimentally infectedwith approximately 1×105 to 2×105 PFU
of MPXV via intraperitoneal (i.p.) and i.n. routes (Xiao et al., 2005). The
MPXV strain utilized (MPX-2003) was isolated from a skin lesion of a
human infected with MPXV during the 2003 outbreak in the United
States. Neither route of infection with MPX-2003 produced histo-
pathologic abnormalities in the heart, pancreas, kidneys, adrenal
glands, or gastrointestinal tract. The i.p. infection route was uniformly
lethal and produced necrosis of the spleen, liver, and abdominal
adipose tissue in 3 of 3 prairie dogs. The i.n. infection route did not
produce necrosis in the spleen or liver in 5 of 5 prairie dogs, but it did
produce necrosis of the thymus andmediastinal lymph nodes in some
Fig. 5. (A) Gall bladder, hemorrhage in submucosa, arrow, bar=100 μm; (B) Brain, hemorrhage, arrow, bar=100 μm. A and B are from dormice that were found dead on days 8 and 9,
respectively, following a lethal infection with MPXV-ZAI-79. (C) Nasal mucosa, syncytia, arrow; numerous necrotic cells with B-type intracytoplasmic viral inclusions, arrowhead,
bar=10 μm; (D) Liver, B-type intracytoplasmic viral inclusions, arrows; hepatic necrosis is demonstrated in the top half of the photo, bar=10 μm. C and D are from dormice that were
sacriﬁced on days 8 and 6 after receiving a lethal MPXV-ZAI-79 i.n. inoculate, respectively.
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the lungs of 3 of 5 prairie dogs. Death occurred in 3 of 5 prairie dogs
infected via the i.n. route; the 2 surviving prairie dogs did not haveTable 1
Histopathological ﬁndings of select tissue from dormicea infected with a lethal dose of
MPXV-ZAI-79
Tissue Morphological
diagnosis
Distribution Frequency
Nasal mucosa Necrosis Diffuse 100% (16/16)
Hemorrhage Multifocal
Liver Necrosis Mutifocal to coalescing 100% (16/16)
Hemorrhage Diffuse
Vacuolar degeneration Diffuse
Spleen Necrosis Diffuse 100% (16/16)
Hemorrhage Diffuse
Lung Hemorrhage Multifocal 100% (16/16)
Stomach Hemorrhage Multifocal 100% (16/16)
Lymph node
(submandibular)
Necrosis Diffuse 100% (14/14)
Hemorrhage Multifocal 71% (10/14)
Adrenal gland Hemorrhage Multifocal to coalescing 100% (16/16)
Necrosis Diffuse 56% (9/16)
Pancreas Hemorrhage Multifocal 94% (15/16)
Thymus Necrosis Multifocal to coalescing 93% (14/15)
Bone marrow Necrosis Multifocal 91% (10/11)
Heart Hemorrhage Multifocal 87% (13/15)
Small intestine Hemorrhage Multifocal 75% (12/16)
Gall bladder Hemorrhage Diffuse 75% (9/12)
Kidney Hemorrhage Multifocal 63% (10/16)
Brain Hemorrhage Multifocal 56% (9/16)
a All dormice (n=16) were found dead; mean time to death was 9.3±1.5 days.signiﬁcant histopathological lesions when their tissues were exam-
ined following euthanasia on day 25 p.i.
The ground squirrel was also experimentally infected with
approximately 1×105 to 2×105 PFU of MPX-2003 via i.p. and i.n.
routes (Tesh et al., 2004). Both routes were uniformly lethal for the 10
ground squirrels tested. Regardless of the route of infection, all ground
squirrels exhibited necrosis of the liver and spleen. Additionally, some
i.n. infected ground squirrels demonstrated consolidation and inter-
stitial inﬂammation of pulmonary tissue and necrosis of peribronchial
lymphoid tissue. Necrosis in other lymph nodes was also noted.
Another study (Sbrana et al., 2007) utilizing ground squirrels
compared the pathology following the subcutaneous injection with
100 PFU of either MPX Z79 (same strain as MPXV-ZAI-79) or MPX
US03 (same strain as MPX-2003). Both strains were 100% lethal at the
same virus dose for the 40 ground squirrels tested, but the MPXV-ZAI-Table 2
Treatment Mortality p value
Dryvaca 0/6 (0%) b0.0001
Cidofovirb 7/36 (19%) b0.0001
Vehicle 41/41 (100%) N/A
a Dormice immunized 4 weeks previously with Dryvax vaccine were solidly protected
from mortality when challenged with 2×104 PFU of MPXV-ZAI-79 by the i.n. route.
b Pooled results from 3 independent experiments using an infectious dose of 75,
4×103, or 5×103 PFU of MPXV-ZAI-79. Dormice were treated with a single dose of
cidofovir 4 h following i.n. challenge with MPXV-ZAI-79. Cidofovir was administered as
described in the experimental protocol.
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bleeding diathesis were observed in ground squirrels infected with
MPX Z79 but infrequently observed in ground squirrels infected with
MPX US03. However, Tesh et al. (2004) did not report nosebleeds/
bleeding diathesis in ground squirrels infected with a higher dose of
the MPX-2003 strain administered via i.p or i.n. routes.
Other rodents evaluated for their susceptibility to MPXV were
the cotton rat and the multimammate mouse/natal mastomys
(Wilson, 1993, 2005). Marennikova et al. (1998) reported the cotton
rat (Sigmodon hispidus) as very susceptible to MPXV; MPXV strain
and dose was not reported. The cotton rat was described as having
acute generalized illness with difﬁcultly breathing, coughing,
rhinitis, conjunctivitis, and progressive emaciation following the i.
n. administration of MPXV; this route of administration caused 50%
mortality. Moreover, a more severe disease course and 100% mor-
tality was noted with this rodent following an intravenous inocu-
lation of MPXV.
Takashi Kitamura (personal comm.) described to the World Health
Organization in 1978 the necropsy ﬁndings of MPXV (reported as
strain MPZ; 1×107 PFU) infected multimammate mice (Mastomys
natalensis) as hemorrhagic pleuritis or peritonitis and inﬂammatory
hyperemia in multiple organs following the i.p. inoculation of MPXV.
A non-human primate model for human MPXV and possibly
smallpox diseases is the cynomolgus monkey (Macaca fascicularis;
Zaucha et al., 2001). Histopathology of this species following lethal
doses of aerosolized MPXV-ZAI-79 (inhaled doses of 1×104 to
1.41×105 PFU) demonstrated necrotizing lesions at all affected sites
which included: lungs, lymph nodes, thymus, spleen, skin, oral
mucosa, gastrointestinal tract, and reproductive systems. Hepatic
involvement was uncommon. The monkeys died naturally or were
killed 9 to 17 days p.i.; cases of natural death were attributed to
ﬁbrinonecrotic bronchopneumonia.
When compared to other rodent models which are presently being
explored forMPXV research, dormice havemany traits similar to those
of laboratory mice. This similarity enables the successful propagation
and maintenance of dormice within a research vivarium and allows
for an accessible supply of dormice with a deﬁned health status.
Dormice can easily utilize customary rodent caging and accessories. In
our studies, cidofovir signiﬁcantly protected against a lethal MPXV-
ZAI-79 infection and the Dryvax vaccine when administered 28 days
prior to a lethal MPXV-ZAI-79 infection was solidly protective. These
ﬁndings support the applicability of the dormouse in pathogenesis,
vaccine, and therapeutic studies of MPXV.
Materials and methods
Animals
The FDA-Center for Veterinary Medicine granted permission for
the procurement of dormice from Ohio and Illinois animal vendors
(see Acknowledgements) and the use of this species inMPXV research.
The Institutional Animal Care and Use Committee at the Saint Louis
School of Medicine approved all experimental protocols. All experi-
mental animal procedures were completed in an ABSL-3 facility where
dormice were housed in large ventilated microisolator cages (M.I.C.E.
system cages, Animal Care Systems, Centennial, Colorado). A standard
rodent diet (Teklad Global 18% Protein Rodent Diet) and water were
provided ad libitum. A nesting area (Techniplast Mouse House) and
corn cob bedding were provided in each cage where no more than 4
dormice were housed. All dormice were acclimatized to their
respective ABSL-3 cages 7 days prior to infection. Dormice utilized
in these studies were generally 2–3 months of age.
Taxonomy of the dormouse was completed via morphometric
analysis of skulls by Dr. Mary Ellen Holden-Musser. This dormouse
species was identiﬁed as G. kelleni which is native to Africa; its
common name is Kellen's African Dormouse (Wilson, 2005).Cells and virus
The strain of MPXV used in themajority of studies wasMPXV-ZAI-79
which was isolated from a fatal human case in Zaire during 1979
(Democratic Republic of the Congo; Zaucha et al., 2001). In one study,
MPXV-COP-58, aWest African strain of MPXV isolated from cynomolgus
macaques in1958wasutilized (VonMagnus et al.,1959). Thevirus strains
were propagated on BSC-1 cell monolayers which were grown in Eagle's
minimum essential medium (EMEM; Bio-Whittaker, Walkersville, MD)
as previously described (Chen et al., 1992).
Antiviral compounds and vaccine
Cidofovir was provided as a gift from Mitch Hitchcock of Gilead
Sciences Inc., (lot: A201A1, 75mg/ml). Dryvax vaccinewas provided by
the CDC.
Pathology examination
After external and internal gross examination of each dormouse
carcass, selected tissues were immersion-ﬁxed in 10% neutral-
buffered formalin and then routinely processed to generate parafﬁn
sections which were stained with hematoxylin-and-eosin. Tissues
selected for microscopic examination: brain, submandibular lymph
node, salivary glands, heart, thymus, lung, kidney, adrenal gland, liver,
gall bladder, spleen, bonemarrow, stomach, small intestine, colon, and
pancreas. Sections of nasal tissue were also routinely processed and
stained after ﬁxation and decalciﬁcation.
Virus assay
Lung, liver, and spleen were ground with tissue homogenizers which
contained ameasuredamountof phosphatebuffered saline (PBS;without
Ca+2 and Mg+2) with 1% fetal calf serum. Nasal lavages and blood were
serially diluted in the samestate as theywere collected. Virus infectivityof
all tissue, nasal lavages, and bloodwasmeasured by plating serial 10-fold
dilutions on monolayers of BSC-1 cells, which were overlayed with
carboxylmethyl cellulose as previously described (Chen et al., 1992).
Experimental infection
For all studies involving the i.n. administration of MPXV, dormice
were anesthetizedwith intraperitoneal injections of a ketamine (9mg/
ml) and xylazine (1mg/ml)mixture at 0.1ml/10 g of bodyweight. Once
anesthetized, each dormouse was securely positioned in a dorsal
recumbent position on a 60 degree incline and one or both nostrils
were inoculated with PBS w/o Ca+2 and Mg+2 alone or containing the
speciﬁed MPXV strain via a micropipette. The dormice were main-
tained in this position for 5 min and then returned to their cages for
recovery. Dormice were weighed every-other-day and observed daily
for morbidity and mortality over the duration of each study. For the
study examining virus spread and disease course, 104 dormice were
infectedwith a lethal dose ofMPXV-ZAI-79 (2×104 PFU). Groups of 6–8
infected dormice were humanely euthanized every 24 h with carbon
dioxide; this was continued through day 8 p.i., a point at which there
were no remaining dormice that survived infection. Spleen, liver,
blood, lung, and nasal lavages were collected for virus infectivity and
tissues from 2 of these dormice (both genders) at each time point were
collected for histopathology. Each nasal lavage utilized 0.5 ml of PBS
containing 1% fetal calf serum. In order to prevent blood contamination
of nasal lavage ﬂuid, the lavage was administered retrograde with a
syringe and 18 gauge needle via the nasopharyngeal meatus.
During one study, dormice (n=13) were infected with 1.4×104 PFU
ofMPXV-ZAI-79 via a left footpad injection. These dormiceweremade
temporarily unconscious due to a very brief exposure to a CO2O2 gas
mixture immediately before the footpad injection.
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Dormice in the study testing the efﬁcacy of Dryvax were initially
vaccinated with Dryvax (10 μl of a 1:10 dilution containing
approximately 1×105 PFU) or the vaccine diluent (10 μl) via an
injection into the left hind limb footpad. Four weeks later, each
dormouse was challenged i.n. with a lethal dose of MPXV-ZAI-79. All
dormice were observed daily for morbidity and mortality for the
following 21 days.
Dormice in studies involving cidofovir were initially infected i.n.
with a lethal dose of MPXV-ZAI-79 and 4 h later they were injected i.p.
with 2 mg (0.1 ml of 20 mg/ml solution; 100 mg/kg) of cidofovir or
0.1 ml of sterile saline alone. All dormice were observed daily for
morbidity and mortality for the following 21 days.
Statistical methods
Statistical signiﬁcance of difference was determined by the t test.
pb0.05 was considered signiﬁcant.
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